Zacks Investment Research Raises Crowdstrike (NASDAQ:CRWD) Price Target to $78.00

Crowdstrike (NASDAQ:CRWD) had its price objective lifted by Zacks Investment Research to $78.00 in a research report released on Monday, 24/7 WallStreet reports.

Several other analysts have also recently weighed in on CRWD. Barclays upped their price objective on shares of Crowdstrike from $75.00 to $77.00 and gave the stock an overweight rating in a research note on Friday, December 6th. DA Davidson began coverage on shares of Crowdstrike in a research note on Wednesday, November 27th. They set a neutral rating on the stock. Goldman Sachs Group raised shares of Crowdstrike from a sell rating to a neutral rating and decreased their price objective for the stock from $66.00 to $55.00 in a research note on Tuesday, November 12th. Piper Jaffray Companies began coverage on shares of Crowdstrike in a research note on Tuesday, December 10th. They set an overweight rating and a $70.00 price objective on the stock. Finally, Robert W. Baird decreased their price objective on shares of Crowdstrike from $75.00 to $65.00 and set a neutral rating on the stock in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average price target of $76.10.

Shares of CRWD opened at $61.56 on Monday. The company has a 50-day simple moving average of $52.14 and a 200-day simple moving average of $65.16. Crowdstrike has a 52 week low of $44.58 and a 52 week high of $101.88.

Crowdstrike (NASDAQ:CRWD) last announced its quarterly earnings data on Thursday, December 5th. The company reported ($0.07) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.12. The company had revenue of $125.10 million for the quarter, compared to analyst estimates of $118.79 million. The firm’s quarterly revenue was up 88.4% compared to the same quarter last year. Equities analysts predict that Crowdstrike will post -1.03 EPS for the current year.

In related news, Director Pincus Private Equity Warburg sold 2,422,500 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $49.70, for a total value of $120,398,250.00. Following the transaction, the director now directly owns 2,422,500 shares in the company, valued at $120,398,250. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Gerhard Watzinger sold 100,000 shares of the stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $48.87, for a total transaction of $4,887,000.00. Following the completion of the transaction, the director now owns 100,000 shares in the company, valued at $4,887,000. The disclosure for this sale can be found here. Insiders have sold 7,957,350 shares of company stock worth $412,457,590 over the last quarter.

A number of hedge funds and other institutional investors have recently made changes to their positions in CRWD. Warburg Pincus LLC acquired a new position in Crowdstrike in the second quarter valued at approximately $3,751,769,000. Vanguard Group Inc. acquired a new position in Crowdstrike in the second quarter valued at approximately $85,696,000. Jericho Capital Asset Management L.P. lifted its holdings in Crowdstrike by 155.3% in the third quarter. Jericho Capital Asset Management L.P. now owns 2,050,104 shares of the company’s stock valued at $119,542,000 after buying an additional 1,247,169 shares during the period. Price T Rowe Associates Inc. MD acquired a new position in Crowdstrike in the second quarter valued at approximately $68,481,000. Finally, Whale Rock Capital Management LLC acquired a new position in Crowdstrike in the second quarter valued at approximately $48,300,000. Institutional investors and hedge funds own 35.26% of the company’s stock.

Recommended Story: Closed-End Mutual Funds

Get a free copy of the Zacks research report on Crowdstrike (CRWD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Crowdstrike (NASDAQ:CRWD)

Receive News & Ratings for Crowdstrike Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crowdstrike and related companies with MarketBeat.com's FREE daily email newsletter.